Investors should take note of NYSE:HAE, a growth stock that remains attractively priced.

Last update: Aug 28, 2024

Discover HAEMONETICS CORP/MASS (NYSE:HAE), an undervalued growth gem identified by our stock screener. NYSE:HAE is shining in terms of growth metrics, and it's also displaying strong financial health and profitability. What's more, it retains an appealing valuation. We'll break it down further.

Evaluating Growth: NYSE:HAE

A key component of ChartMill's stock assessment is the Growth Rating, which spans from 0 to 10. This rating evaluates diverse growth factors, such as EPS and revenue growth, considering both past performance and future projections. NYSE:HAE has received a 7 out of 10:

HAE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.86%, which is quite good.
Measured over the past years, HAE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.74% on average per year.
HAE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.47%.
HAE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.40% yearly.
Based on estimates for the next years, HAE will show a quite strong growth in Revenue. The Revenue will grow by 10.74% on average per year.
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

Valuation Examination for NYSE:HAE

ChartMill provides a Valuation Rating to every stock, ranging from 0 to 10. This rating assesses various valuation aspects, comparing price to earnings and cash flows, while considering factors like profitability and growth. NYSE:HAE boasts a 6 out of 10:

Based on the Price/Earnings ratio, HAE is valued cheaper than 87.96% of the companies in the same industry.
When comparing the Price/Earnings ratio of HAE to the average of the S&P500 Index (30.01), we can say HAE is valued slightly cheaper.
Based on the Price/Forward Earnings ratio, HAE is valued cheaper than 93.19% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of HAE to the average of the S&P500 Index (21.67), we can say HAE is valued slightly cheaper.
86.39% of the companies in the same industry are more expensive than HAE, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HAE indicates a somewhat cheap valuation: HAE is cheaper than 77.49% of the companies listed in the same industry.
The excellent profitability rating of HAE may justify a higher PE ratio.
A more expensive valuation may be justified as HAE's earnings are expected to grow with 16.85% in the coming years.

Health Analysis for NYSE:HAE

ChartMill employs its own Health Rating for stock assessment. This rating, ranging from 0 to 10, is calculated by examining various liquidity and solvency ratios. In the case of NYSE:HAE, the assigned 5 reflects its health status:

HAE has a Altman-Z score of 2.77. This is in the better half of the industry: HAE outperforms 63.87% of its industry peers.
HAE's Debt to FCF ratio of 17.79 is fine compared to the rest of the industry. HAE outperforms 71.20% of its industry peers.
A Current Ratio of 3.76 indicates that HAE has no problem at all paying its short term obligations.
HAE has a Quick Ratio of 2.33. This indicates that HAE is financially healthy and has no problem in meeting its short term obligations.

Analyzing Profitability Metrics

ChartMill employs its own Profitability Rating system for stock evaluation. This score, ranging from 0 to 10, is derived from an analysis of diverse profitability metrics and margins. In the case of NYSE:HAE, the assigned 8 is noteworthy for profitability:

With an excellent Return On Assets value of 4.52%, HAE belongs to the best of the industry, outperforming 81.68% of the companies in the same industry.
HAE has a better Return On Equity (12.69%) than 88.48% of its industry peers.
With an excellent Return On Invested Capital value of 7.17%, HAE belongs to the best of the industry, outperforming 85.86% of the companies in the same industry.
HAE has a better Profit Margin (8.61%) than 81.68% of its industry peers.
HAE's Profit Margin has improved in the last couple of years.
The Operating Margin of HAE (15.43%) is better than 86.39% of its industry peers.
In the last couple of years the Operating Margin of HAE has grown nicely.
HAE's Gross Margin has improved in the last couple of years.

Our Affordable Growth screener lists more Affordable Growth stocks and is updated daily.

For an up to date full fundamental analysis you can check the fundamental report of HAE

Disclaimer

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.